Structure based molecular inhibition of Caspase-8 for treatment of multi-neurodegenerative diseases using known

Khurshid Ahmad1, Saif Khan2, Mohd Adil3

  • 1Department of Biosciences, Integral University, Lucknow.

Bioinformation
|June 27, 2014
PubMed

Insights

Natural compounds rosmarinic acid and curcumin show potential for inhibiting Caspase-8, a key factor in neurodegenerative diseases like Alzheimer's and Parkinson's. Further research is needed to confirm their therapeutic benefits.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Neurodegenerative disorders are characterized by excessive neuronal apoptosis.
  • Caspase-8, an initiator caspase, is a critical mediator of neuronal apoptosis and implicated in diseases like Alzheimer's, Parkinson's, and Huntington's.
  • Inhibiting Caspase-8 presents a potential therapeutic strategy for neurodegenerative conditions.

Purpose of the Study:

  • To investigate the molecular interactions of selected natural compounds with anti-neurodegenerative properties against Caspase-8.
  • To identify potent natural inhibitors of Caspase-8 for potential therapeutic applications.

Main Methods:

  • Molecular docking simulations were performed using Autodock4.2.
  • The study focused on the binding interactions between Caspase-8 and selected natural compounds.
  • Binding energy (ΔG) was calculated to assess inhibitory potential.

Main Results:

  • Rosmarinic acid exhibited a binding energy of -7.10 Kcal/mol with Caspase-8.
  • Curcumin demonstrated a binding energy of -7.08 Kcal/mol with Caspase-8.
  • Both rosmarinic acid and curcumin were identified as potent inhibitors of Caspase-8.

Conclusions:

  • Rosmarinic acid and curcumin show significant potential as Caspase-8 inhibitors.
  • These compounds may offer a novel therapeutic avenue for neurodegenerative disorders.
  • Further in vitro and in vivo studies are required to validate their anti-neurodegenerative efficacy.